Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001171843-17-006256
Filing Date
2017-10-24
Accepted
2017-10-24 18:46:16
Documents
1
Period of Report
2017-10-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 formfour.html 4  
1 FORM 4 formfour.xml 4 3984
  Complete submission text file 0001171843-17-006256.txt   5296
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Issuer) CIK: 0001582313 (see all company filings)

EIN.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G4W8
Business Address
PIMSTONE SIMON N. (Reporting) CIK: 0001620084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36687 | Film No.: 171151833